Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis
April M. Adkison, … , Diane G. Kelley, Christine T.N. Pham
April M. Adkison, … , Diane G. Kelley, Christine T.N. Pham
Published February 1, 2002
Citation Information: J Clin Invest. 2002;109(3):363-371. https://doi.org/10.1172/JCI13462.
View: Text | PDF
Article

Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis

  • Text
  • PDF
Abstract

Leukocyte recruitment in inflammation is critical for host defense, but excessive accumulation of inflammatory cells can lead to tissue damage. Neutrophil-derived serine proteases (cathepsin G [CG], neutrophil elastase [NE], and proteinase 3 [PR3]) are expressed specifically in mature neutrophils and are thought to play an important role in inflammation. To investigate the role of these proteases in inflammation, we generated a mouse deficient in dipeptidyl peptidase I (DPPI) and established that DPPI is required for the full activation of CG, NE, and PR3. Although DPPI–/– mice have normal in vitro neutrophil chemotaxis and in vivo neutrophil accumulation during sterile peritonitis, they are protected against acute arthritis induced by passive transfer of monoclonal antibodies against type II collagen. Specifically, there is no accumulation of neutrophils in the joints of DPPI–/– mice. This protective effect correlates with the inactivation of neutrophil-derived serine proteases, since NE–/– × CG–/– mice are equally resistant to arthritis induction by anti-collagen antibodies. In addition, protease-deficient mice have decreased response to zymosan- and immune complex–mediated inflammation in the subcutaneous air pouch. This defect is accompanied by a decrease in local production of TNF-α and IL-1β. These results implicate DPPI and polymorphonuclear neutrophil–derived serine proteases in the regulation of cytokine production at sites of inflammation.

Authors

April M. Adkison, Sofia Z. Raptis, Diane G. Kelley, Christine T.N. Pham

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Analysis of PMN-derived serine proteases in DPPI–/– mice. NE (a) and CG ...
Analysis of PMN-derived serine proteases in DPPI–/– mice. NE (a) and CG (b) protein expression in DPPI–/– bone marrow lysates. β-actin served as control for protein content. Note the markedly reduced level of immunoreactive CG in DPPI–/– bone marrow lysate compared with WT. (c) S1 nuclease protection assay revealed equivalent levels of CG mRNA in DPPI–/– and WT bone marrow lysate. β2 microglobulin (β2m) served as control for RNA loading. (d) DPPI–/– bone marrow cells and NE–/– bone marrow cells have equivalent residual levels of NE activity. (e) Both DPPI–/– and CG–/– bone marrow cells have no detectable hydrolysis of the CG-specific peptide substrate. (f) Conversion of the PR3 substrate by DPPI–/– bone marrow cell lysate was reduced by 80% compared with WT. Relative enzyme activity was measured at OD405 per 105 bone marrow cells and values represent mean activity ± SEM of at least three animals.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts